<DOC>
	<DOCNO>NCT01341132</DOCNO>
	<brief_summary>This study aim determine whether gadoxetate disodium ( Eovist ) enhance magnetic resonance imaging ( MRI ) high sensitivity detect hepatocellular carcinoma ( Liver Cancer ) comparison multi-detector compute tomography ( CT ) .</brief_summary>
	<brief_title>Evaluation Cirrhosis Malignant Hepatic Lesions Using Novel MR Contrast Agents</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Alphafeto protein &gt; 400 ng / mL prior ultrasound mass suspicious hepatic malignancy . clinical risk hepatocellular carcinoma prior multidetector CT mass suspicious possible hepatocellular carcinoma Glomerulofiltration rate &lt; 50 mL/ min/1.73 m2 base creatinine measurement within three month MR study Previous diagnosis hepatic malignancy Any condition would discount ability MRI scan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>HCC</keyword>
	<keyword>Hepatocellular Carcinoma</keyword>
	<keyword>MRI</keyword>
	<keyword>Liver</keyword>
</DOC>